{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:26:55Z","timestamp":1757618815217,"version":"3.44.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T00:00:00Z","timestamp":1752364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09751-z","type":"journal-article","created":{"date-parts":[[2025,7,13]],"date-time":"2025-07-13T17:40:03Z","timestamp":1752428403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rare variants modulating phenotype in NF1 carriers"],"prefix":"10.1038","volume":"15","author":[{"given":"Elena","family":"Pasquinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Casamassima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omaima","family":"Belakhdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Minetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Canitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"Martellucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvadora Tindara","family":"Miano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Petrioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Baldassarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina","family":"D\u2019Aurizio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Fallerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Renieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,13]]},"reference":[{"key":"9751_CR1","unstructured":"Carton, C. et al. on behalf of the ERN GENTURIS NF1 Tumour Management Guideline Group. ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1. Clin. Med. 56, (2023)."},{"key":"9751_CR2","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/ajmg.a.63346","volume":"191","author":"A Goetsch Weisman","year":"2023","unstructured":"Goetsch Weisman, A. et al. Neurofibromatosis- and schwannomatosis-associated tumors: approaches to genetic testing and counseling considerations. Am. J. Med. Genet. A. 191, 2467\u20132481. https:\/\/doi.org\/10.1002\/ajmg.a.63346 (2023).","journal-title":"Am. J. Med. Genet. A"},{"key":"9751_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1470-2045(23)00156-0","volume":"24","author":"C Huntley","year":"2023","unstructured":"Huntley, C. et al. Utility of polygenic risk scores in UK cancer screening: a modelling analysis. Lancet Oncol. 24, 658\u2013668. https:\/\/doi.org\/10.1016\/S1470-2045(23)00156-0 (2023).","journal-title":"Lancet Oncol."},{"key":"9751_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki, H., Mautner, V. F. & Cooper, D. N. Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum. Genet. 136, 349\u2013376 (2017).","journal-title":"Hum. Genet."},{"key":"9751_CR5","doi-asserted-by":"crossref","unstructured":"Cichowski, K. & Jacks, T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 104, 593\u2013604 (2001).","DOI":"10.1016\/S0092-8674(01)00245-8"},{"key":"9751_CR6","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.1523\/JNEUROSCI.4693-04.2005","volume":"25","author":"B Dasgupta","year":"2005","unstructured":"Dasgupta, B. & Gutmann, D. H. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J. Neurosci. 25, 5584\u20135594 (2005).","journal-title":"J. Neurosci."},{"key":"9751_CR7","first-page":"101","volume":"25","author":"T Fortin","year":"2023","unstructured":"Fortin, T. et al. Alterations in DNA damage response and repair pathways in neurofibromatosis type 1-associated gliomas. Neuro-Oncol. 25, 101\u2013113 (2023).","journal-title":"Neuro-Oncol."},{"key":"9751_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"9751_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation. Genet. Med. 17, 405\u2013424 (2015).","journal-title":"Genet. Med."},{"key":"9751_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF00197259","volume":"88","author":"K Stephens","year":"1992","unstructured":"Stephens, K. et al. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum. Genet. 88, 279\u2013282. https:\/\/doi.org\/10.1007\/BF00197259 (1992).","journal-title":"Hum. Genet."},{"key":"9751_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0883073812446310","volume":"28","author":"EA Soucy","year":"2013","unstructured":"Soucy, E. A. et al. Height assessments in children with neurofibromatosis type 1. J. Child. Neurol. 28, 303\u2013307. https:\/\/doi.org\/10.1177\/0883073812446310 (2013).","journal-title":"J. Child. Neurol."},{"key":"9751_CR12","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.5455\/annalsmedres.2020.07.714","volume":"28","author":"HK Ucar","year":"2021","unstructured":"Ucar, H. K. et al. Short stature and insulin-like growth factor-I in neurofibromatosis type 1. Ann. Med. Res. 28, 1763\u20131766. https:\/\/doi.org\/10.5455\/annalsmedres.2020.07.714 (2021).","journal-title":"Ann. Med. Res."},{"key":"9751_CR13","doi-asserted-by":"publisher","first-page":"dgaa138","DOI":"10.1210\/clinem\/dgaa138","volume":"105","author":"C Santoro","year":"2020","unstructured":"Santoro, C. et al. Pretreatment endocrine disorders due to optic pathway gliomas in pediatric neurofibromatosis type 1: multicenter study. J. Clin. Endocrinol. Metab. 105, dgaa138. https:\/\/doi.org\/10.1210\/clinem\/dgaa138 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9751_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s42000-022-00411-9","volume":"22","author":"SL Pinheiro","year":"2023","unstructured":"Pinheiro, S. L. et al. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients. Horm. (Athens). 22, 79\u201385. https:\/\/doi.org\/10.1007\/s42000-022-00411-9 (2023).","journal-title":"Horm. (Athens)"},{"key":"9751_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1677\/erc.0.0060303","volume":"6","author":"P Feuillan","year":"1999","unstructured":"Feuillan, P., Merke, D. W., Leschek, E. W. & Cutler, G. B. Jr. Use of aromatase inhibitors in precocious puberty. Endocr. Relat. Cancer. 6, 303\u2013306. https:\/\/doi.org\/10.1677\/erc.0.0060303 (1999).","journal-title":"Endocr. Relat. Cancer"},{"key":"9751_CR16","doi-asserted-by":"publisher","unstructured":"Mensink, K. A. et al. Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. J. Med. Genet. 43 (e8). https:\/\/doi.org\/10.1136\/jmg.2005.034256 (2006).","DOI":"10.1136\/jmg.2005.034256"},{"key":"9751_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2214\/AJR.12.8565","volume":"199","author":"N.B Patel","year":"2012","unstructured":"PatelN.B. & StacyG.S. Musculoskeletal manifestations of neurofibromatosis type 1. Am. J. Roentgenol. 199, 88\u2013106. https:\/\/doi.org\/10.2214\/AJR.12.8565 (2012).","journal-title":"Am. J. Roentgenol."},{"key":"9751_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12031-024-02271-x","volume":"74","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Identification of pathogenic missense mutations of NF1 using computational approaches. J. Mol. Neurosci. 74, 94. https:\/\/doi.org\/10.1007\/s12031-024-02271-x (2024).","journal-title":"J. Mol. Neurosci."},{"key":"9751_CR19","unstructured":"Safanov, A. et al. Pathogenic NF1 variants in individuals without a clinical diagnosis of NF1 and implications for cancer susceptibility. Nat. Commun.  16, 3121 10.1038\/s41467-025-57077-1 (2025)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09751-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09751-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09751-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:57:32Z","timestamp":1757228252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09751-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9751"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09751-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,13]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the ethical principles established by the Declaration of Helsinki. All participants provided written informed consent, and the procedures were approved by the institutional ethics committee (Regional Ethics Committee for Clinical Trials of the Tuscany Region \u2013 South-East Area). Written informed consent was obtained from all patients and or their legal guardian\/parents whose images in this publication allow for personal identification.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The requirement for ethical approval for this study was waived by the Regional Ethics Committee for Clinical Trials of the Tuscany Region \u2013 South-East Area, which convened on August 22, 2023.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval waiver"}},{"value":"The need for informed consent was waived by the Regional Ethics Committee for Clinical Trials of Tuscany - South East Area Section, which convened on August 22, 2023.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent waiver"}}],"article-number":"25337"}}